REQUEST A DEMO
Total
USD $0.00
Search more companies

Megalabs - Pharma S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Megalabs - Pharma S.A. Profile Updated: December 15, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Megalabs - Pharma S.A. is a company in Ecuador, with a head office in Quito. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on September 24, 1987. Megalabs - Pharma S.A. currently employs 113 (2021) people. In 2022, the company reported a net sales revenue increase of 9.87%. During that time, Megalabs - Pharma S.A.’s total assets grew by 6.01%. In, 2022, the company’s net profit margin increased by 0.33%.

Headquarters
Av. Coruna N27-36, la Moraleja Bldg. , Floor 10
Quito; Pichincha;

Contact Details: Purchase the Megalabs - Pharma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Megalabs - Pharma S.A. report to view the information.
Outstanding Shares:
Purchase the Megalabs - Pharma S.A. report to view the information.
Registered Capital:
Purchase the Megalabs - Pharma S.A. report to view the information.
Financial Auditors:
Purchase the Megalabs - Pharma S.A. report to view the information.
Incorporation Date:
September 24, 1987
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Subsidiaries
Laboratorios Ecuarowe S.A.
0.05%
Company Performance
Financial values in the chart are available after Megalabs - Pharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
9.87%
Total operating revenue
9.23%
Operating profit (EBIT)
19.56%
EBITDA
20.3%
Net Profit (Loss) for the Period
23.96%
Total assets
6.01%
Total equity
118.33%
Operating Profit Margin (ROS)
0.41%
Net Profit Margin
0.33%
Return on Equity (ROE)
-43.82%
Debt to Equity Ratio
-5.53%
Quick Ratio
0.09%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?